The recent SIO-ASCO joint guidelines on integrative therapies for cancer pain found evidence to support the use of acupuncture aromatase inhibitor-related joint pain, general cancer pain and musculoskeletal pain [15]. This evidence concerns the gene CYP19A1 and cancer.